0001140361-21-021503.txt : 20210617
0001140361-21-021503.hdr.sgml : 20210617
20210617192607
ACCESSION NUMBER: 0001140361-21-021503
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210615
FILED AS OF DATE: 20210617
DATE AS OF CHANGE: 20210617
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BEDU-ADDO FRANK
CENTRAL INDEX KEY: 0001770756
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37568
FILM NUMBER: 211026532
MAIL ADDRESS:
STREET 1: 300 CONNELL DRIVE
STREET 2: SUITE 400
CITY: BERKELEY HEIGHTS
STATE: NJ
ZIP: 07922
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PDS Biotechnology Corp
CENTRAL INDEX KEY: 0001472091
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 264231384
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 25B VREELAND ROAD
STREET 2: SUITE 300
CITY: FLORHAM PARK
STATE: NJ
ZIP: 07932
BUSINESS PHONE: 800-208-3343
MAIL ADDRESS:
STREET 1: 25B VREELAND ROAD
STREET 2: SUITE 300
CITY: FLORHAM PARK
STATE: NJ
ZIP: 07932
FORMER COMPANY:
FORMER CONFORMED NAME: Edge Therapeutics, Inc.
DATE OF NAME CHANGE: 20090911
4
1
form4.xml
FORM 4
X0306
4
2021-06-15
0001472091
PDS Biotechnology Corp
PDSB
0001770756
BEDU-ADDO FRANK
C/O PDS BIOTECHNOLOGY CORPORATION
25B VREELAND ROAD
FLORHAM PARK
NJ
07932
true
true
President/CEO
Common Stock
2021-06-15
4
M
0
53174
6.57
A
673681
D
Common Stock
2021-06-15
4
F
0
27166
12.86
D
646515
D
Stock Option (Right to Buy)
6.57
2021-06-15
4
M
0
53174
0
D
2021-07-27
Common Stock
53174
0
D
On June 15, 2021, Mr. Bedu-Addo made a net exercise of 53,174 stock options, resulting in his acquisition of 26,008 common shares of the Issuer. The transaction was made pursuant to an exception to a lock-up agreement between Mr. Bedu Addo and Cantor Fitzgerald & Co.in connection with a public offering of common shares by the Issuer which closed on June 17, 2021.
The Stock Option is fully vested in accordance with its terms.
/s/ Frank Bedu-Addo
2021-06-17